Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Naltrexone for HIV-infected Men With Alcohol Use Disorder
NCT01377168Phase 4Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- May 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in alcohol use disorder (AUD), sponsored by Fred Hutchinson Cancer Center. Started May 2014; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01377168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377168.